Clinical Trial Update: Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Prostaglandin F2-alpha Eye Drops for Graves' Ophthalmopathy has completed (Bima Study).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Ophthalmopathy

Drugs mentioned

• Prostaglandin F2-alpha Eye Drops (prostaglandin F2-alpha)

Snippet

Sponsor: Cardiff University | Conditions: Graves' Ophthalmopathy | Phase 4 | Status: COMPLETED